We previously demonstrated the suppression of cell-mediated immunity to Listeria monocytogenes by Pseudomonas aeruginosa-induced, macrophage-like cells. The present study was undertaken to evaluate the mechanism for this suppression. P. aeruginosa supernatant was shown to activate macrophages by the criteria of increased bactericidal capacities and increased attachment to glass surfaces. Acquired cellular resistance to L. monocytogenes could also be inhibited by macrophages from L. monocytogenes-pretreated mice. The depression of acquired immunity by P. aeruginosa-or L. monocytogenes-activated macrophages did not appear to be due to a reduction of antigenic stimulus after nonspecific macrophage activation. In contrast, our findings suggest that suppression is mediated by activated macrophages through a prostaglandin-dependent mechanism. In vivo administration of aspirin blocked the immunosuppressive effect of P. aeruginosa-or L. monocytogenes-activated cells. Moreover, the suppressive activity of supernatants of macrophages from Listeria-infected mice was reversed when indomethacin was present during supernatant generation. Finally, prostaglandin El treatment in vivo profoundly inhibited the induction of cell-mediated immunity to L.
A variety of products of microbial origin can modulate the immune system (9, 31) . Some bacterial agents can suppress various phases of specific immunity (4, 7, 30, 32) . Most of the bacteria implicated in suppression are facultative or obligate intracellular parasites that can multiply and survive in monocytes and/or macrophages. Immunosuppression may be relevant for the infectious process itself. Indeed, several examples of natural and experimental chronic infections have been described in which progressive uncontrolled infection is associated with a depressed cell-mediated immunity (CMI) (2, 32, 39) . But immunosuppression might be beneficial for the host when the suppressor mechanisms turn off the immune response after infection has subsided. Few data exist on the role and mechanisms of suppression in CMI to intracellular bacteria.
It has been previously reported that Pseudomonas aeruginosa decreases acquired cellular immunity to the facultative intracellular pathogen Listeria monocytogenes (27) . P. aeruginosa injection results in the development of adherent, macrophage-like suppressor cells in the spleen and peritoneal cavity that are capable of preventing immunity of normal recipients against Listeria organisms. The induction of immune response against intracellular bacteria may be influenced by the activities of macrophages as antigenpresenting cells and as nonspecific scavenger phagocytes (24, 36) . Furthermore, macrophages are able to release immunoregulatory molecules (1, 36) . This paper reports results from experiments designed to investigate the mechanism by which macrophages may decrease acquired cellular resistance to L. monocytogenes. Our results show that P. aeruginosa is capable of activating macrophages. Furthermore, Listeria-activated macrophages were shown to depress the acquired resistance to L. monocytogenes. Inhibitors of arachidonic acid metabolism were able to block the in vivo suppression of cellular immunity by P. aeruginosa-or Listeria-activated macrophages or super-* Corresponding author.
natants from these cells. Finally, our results demonstrated that prostaglandin E1 (PGE1) treatment in vivo profoundly disturbs the development of acquired immunity to L. monocytogenes. This study provides in vivo evidence that activated macrophages via arachidonic acid metabolites can suppress CMI to intracellular bacteria.
MATERIALS AND METHODS
Mice. Female Swiss CD-1 mice from Charles River Breeding Laboratories, Inc., Wilmington, Mass., were used when 5 to 6 weeks old.
L. monocytogenes and infection of mice. L. monocytogenes was maintained in a virulent stage by passage in mice and recovery from the spleen. The intravenous (i.v.) 50% lethal dose was 2.77 x 104. All inocula were injected i.v., and the viable counts were confirmed by plate counts with brain heart infusion agar as previously described (28) .
L. monocytogenes spleen colony counts. Viable Listeria organisms in spleens were quantitated at various times after Listeria i.v. infection as previously described (28 P. aeruginosa antigen. Antigen from P. aeruginosa was prepared as previously described (27) and consisted of the supernatant fluid of a heat-killed, 2-week-old, protein-free broth culture.
Assay of macrophage attachment to glass. Peritoneal exudate cells were harvested 3 days after intraperitoneal injection of 1.5 ml of 10% proteose peptone. The adherent cell monolayers were incubated in Leighton tubes at 4 x 106/ml in minimal essential medium. P. aeruginosa antigen (25 Controls received the diluent alone. PGE1 was administered for a total of 8 days, starting 1 day before infection with Listeria organisms. Statistical analysis. The significance of differences between groups was analyzed by Student's t test. Differences in mortality between groups were analyzed by the chi-square test with Yates' correction for continuity.
RESULTS
Effect of P. aeruginosa on Listeria primary-infection. The growth of a sublethal dose of L. monocytogenes in the spleens was studied in P. aeruginosa-treated and untreated mice (Fig. 1 ). Spleens were obtained after 1, 24, 48, and 72 h and 6 days. After 1 h, the number of Listeria organisms was the same in both groups. However, a significant difference, albeit minor at day 1, was observed during the subsequent growth of the bacteria. At the peak time of growth, there were ca. 180-fold more bacteria in the spleens of the untreated group than in the P. aeruginosa-treated group.
Protection against listeriosis by P. aeruginosa. Mortality after infection with L. monocytogenes was significantly reduced in mice treated with P. aeruginosa 1 day before infection. The results of a representative experiment are shown in Fig. 2 .
Effect of P. aeruginosa on macrophages. Attempts were made to determine whether P. aeruginosa might activate macrophages in culture. Potential activation was evaluated by studying alterations in cellular attachment to glass surfaces (6) . Peritoneal macrophages were plated in Leighton tubes, P. aeruginosa supernatant was added, and the cells were incubated for 48 and 72 h at 37°C. The macrophages were activated as judged by morphological criteria (markedly spread) and by adherence capabilities ( Table 1) .
Effect of Listeria-activated macrophages on specific antiListeria immunity. The experiments presented above demonstrated that P. aeruginosa increased macrophage spreading and adherence in vitro and heightened resistance to L. monocytogenes in vivo. We had previously shown the suppressive effects of the spleen and peritoneal macrophages from P. aeruginosa-treated mice on Listeria-acquired immunity (27) . We thought that suppression was a consequence of macrophage activation. An experiment was then set up to determine the effects of Listeria-activated macro- phages on the development of specific Listeria immunity. Activated or normal peritoneal macrophages were injected on the day of Listeria primary infection. Seven days later, mice were challenged with a higher dose of Listeria organisms. Spleens were obtained and assayed for bacterial growth 2 days later. The mice given activated macrophages had more growth of bacteria in the spleens than did mice given normal macrophages or no cells (Fig. 3) . We concluded that activated macrophages injected at the time of immunization decreased the specific anti-Listeria immunity.
Effect of activated macrophages on the Listeria immunizing dose. We tested the capacity of activated macrophages to reduce the Listeria immunizing dose. Peritoneal macrophages from Listeria-treated or untreated mice were injected i.v. into mice that were then infected with Listeria organisms. The number of organisms in the spleens was estimated at 20 min and at 5 and 24 h after Listeria infection. The number of Listeria was the same in spleens of the recipients of normal or Listeria-activated macrophages (Table 2) . We concluded that although activated macrophages were inhibiting Listeria-acquired immunity, they were not acting by decreasing the Listeria immunizing dose.
Effect of inhibitors of prostaglandin synthetase on stippres- sion by activated macrophages of acquired Listeria immunity.
Activated macrophages are able to release large quantities of prostaglandins (1). Thus, we evaluated the possibility that such prostaglandin release was responsible for the suppression of Listeria-acquired immunity. Aspirin was administered to recipients of cells collected from P. aeruginosa-or Listeria-treated mice. Seven days after the primary infection, recipient mice were challenged with Listeria organisms. The spleen assay was made at 48 h. Aspirin blocked the suppressive effect of P. aeruginosa-and Listeriaactivated macrophages (Fig. 4) .
We also sought evidence for. their activity was assessed. Supernatants of activated macrophages suppressed the acquired immunity to L. monocytogenes (Fig. 5 ). This suppression was reversed when indomethacin was present during the generation of supernatants. These results suggest that suppressor macrophages function through prostaglandin synthesis.
Not shown in Fig. 4 (24, 36) .
It has been previously reported that P. aeruginosa depresses acquired resistance to L. monocytogenes (27) . This depression was mediated by an adherent macrophage-like cell population. In the present study, we investigate the mechanism for the inhibitory activity of macrophages. Our experiments show that P. aeruginosa increased macrophage spreading and adherence in vitro. Furthermore, P. aeruginosa-treated mice expressed a heightened resistance to Listeria organisms as measured by spleen bacterial counts and survival after primary infection. Resistance to the facultative intracellular bacterium L. monocytogenes depends ultimately on the acquisition by the host of macrophages with increased bactericidal properties (20) . In vivo protection against Listeria organisms associated with in vitro macrophage activity suggests that P. aeruginosa induces macrophage activation.
Macrophage activation by P. aeruginosa has been previously demonstrated by Fauchere et al. (8) . These authors reported that an acellular extract from P. aeruginosa strongly increases resistance of mice to bacterial infections by inducing an early recruitment of phagocytes and increasing their bactericidal activity.
Furthermore, the present work shows that injection of macrophages activated by Listeria organisms, at the time of immunization, enhanced the susceptibility of mice to a secondary challenge of L. monocytogenes. Macrophages from mice treated by L. monocytogenes (20) as well as those from mice treated with P. aeruginosa have increased bactericidal capacities. The depression of acquired cellular resistance to L. monocytogenes may be a consequence of these enhanced bactericidal capacities. The inoculum of Listeria organisms reduced by activated macrophages may fail to sensitize an adequate number of Listeria T cells. Miyata et al. (22) reported that, in mice pretreated with Corynebacterium parvum, L. monocytogenes is cleared rapidly from the blood, and bacterial growth in the liver and spleen is inhibited effectively during the early phase of infection. Pretreated mice develop lower levels of delayed-type hypersensitivity to bacteria than do untreated immune control mice, but the control levels of delayed-type hypersensitivity could be reached by increasing the chal- lenge dose of bacteria in C. parvum-pretreated mice. Acquired cellular resistance to L. monocytogenes was slightly suppressed in mice pretreated with C. parvum (21) . The authors suggest that the lower levels of delayed-type hypersensitivity and acquired cellular resistance seen in mice pretreated with C. parvum are attributable to an insufficient antigenic stimulus after the accelerated elimination of antigen by nonspecifically activated macrophages. Our data do not support this explanation, since the transfer of activated macrophages has failed to show an increased destruction of Listeria organisms in the spleen of recipient mice.
Recently, Orme and Collins (25) reported that blastogenic responsiveness in vitro both to mitogen and to alloantigen is severely depressed in mice heavily infected by atypical mycobacteria. This depression is not the result of the generation of suppressor T cells but the consequence of an adherent macrophage-like cell population. Furthermore, the authors observed a depressed delayed-type hypersensitivity response to sheep erythrocytes in infected mice. Their study did not show a cell population in the spleens of infected mice that was capable of inhibiting the sheep erythrocyte sensitization process in vivo. However, responsiveness could be restored by increasing the dose of antigen. The authors suggest that the basis of the perturbation of both the in vitro and in vivo assays may lie in activated macrophages. These cells express enhanced phagocytic activity and may rapidly catabolize or inadequately present antigen. As for the data obtained in vitro by these workers, one possibility is that the presence of activated macrophages harvested from infected mice might lead to the depletion of medium and cause a deficiency of nutrients. Along these lines, it could be hypothesized that the consumption by host macrophages of transferred macrophages from P. aeruginosa-or Listeria-treated mice might cause a blockade so that host macrophages would be unable to handle the subsequent infection by Listeria organisms. However, no difference in the ability to deal with Listeria primary infection was observed between macrophage recipients and control mice ( Table 2) . Furthermore, the subsequent demonstration of the inhibiting effect of indomethacin and aspirin do not support this hypothesis.
Other possible mechanisms to explain the in vivo effect of suppressor macrophages should be considered. Activated macrophages are capable of inhibiting immune responses (1) . The suppression of cellular responses by Corynebacteriumor Mycobacterium-activated macrophages has been previously demonstrated (reviewed in reference 26). The inhibitory effects of macrophages are nonspecific and appear to be mediated by soluble products (10) . In the present work, the inhibitory effects of activated macrophages on CMI in vivo appear to be mediated by prostaglandins.
Our experiments showed that the systemic administration of aspirin to mice that are inoculated with spleen cells from P. aeruginosa-treated mice or peritoneal cells from Listeriainfected mice resulted in the reversion of inhibition. Moreover, the inhibitory effect of activated macrophage supernatants was blocked by incubating cells with indomethacin. The fact that two separate prostaglandin synthesis inhibitors prevented the inhibiting effect of the macrophages supports our hypothesis that prostaglandin secretion is one mechanism by which P. aeruginosa-and Listeria-activated cells cause a decrease in acquired immunity. In addition, our observation that the systemic administration of PGE1 perturbed the development of acquired immunity supports the findings mentioned above. PGE1 had no effect on the natural resistance but had a dramatic effect on antigen-specific cellular immunity. The secretion of prostaglandins by suppressor cells induced by bacteria or bacterial products has been previously reported (3, 6, 14, 16, 40) . Kaufmann et al. (18) reported that the proliferation of peritoneal exudate T lymphocytes from L. monocytogenes-immune mice is inhibited by macrophages from L. monocytogenes-or C. parvum-pretreated mice as well as by exogenous PGE2. Macrophage-dependent inhibition of Tcell proliferation could be reversed at least in part by the addition of indomethacin. Such a macrophage-dependent suppressor mechanism could also be relevant under in vivo conditions, since the authors reported (17) that, although pretreatment of mice with C. parvum led to increased protection against infection with Listeria organisms, peritoneal exudate T lymphocytes from C. parvum-inoculated mice are less active in adoptively transferring protection to L. monocytogenes. Our observations corroborate the findings of Kaufmann and co-workers. However, we have extended these findings by demonstrating the in vivo prostaglandin mediation of the inhibitory activity of activated macrophages.
The exact mechanism(s) responsible for the suppressed state has not been defined and is currently under investigation. Many studies have indicated that arachidonic acid metabolites synthesized by monocytes and/or macrophages have important immunoregulatory functions (5, 12, 34) . We believe that the depressed immunity is due to the interference of prostaglandin (produced by activated macrophages) with T-lymphocyte function. It is known that PGE1 has a suppressive effect on lymphokine production (13) . Prostaglandins can potentially have multiple effects at the induction level, also. In vitro studies have demonstrated direct suppression of T-lymphocyte transformation (11, 23) , an event that would be required for the generation of reactive T cells. It has been shown by Snyder et al. (33) that prostaglandins of the E class inhibit the expression of I-region-associated antigen (Ia) on macrophages. This would tend to reduce the amount of antigen presented to T-cells in a recognizable form, thus inhibiting the T-cell activation (37) . Recently Kunkel et al. (19) have shown that methyl-POE1 treatment in vivo profoundly suppresses Ia antigen expression by hypersensitivity granuloma macrophages. Virgin and Unanue (38) recently reported that immune complexes suppress CMI to L. monocytogenes. Immune complexes can induce macrophages to secrete prostaglandins (29) . The inhibition of expression of Ta molecules on macrophages is one mechanism suggested by these authors to explain the suppression. Tweardy et al. (35) demonstrated that immunosuppression in tuberculosis is associated with the alteration of monocyte surface expression of human leukocyte antigen DR, which is the equivalent of the Ia antigen in mice. Thus, activated macrophages could inhibit T-cell-macrophage interaction during antigen presentation by regulating Ia induction through prostaglandin synthesis.
In conclusion, we have demonstrated (i) that there are suppressor mechanisms of cellular immunity to the facultative intracellular pathogen L. monocytogenes that are dependent on activated macrophages and (ii) that products of arachidonic acid are involved in suppression. Thus, the activation of macrophages by T cells, a process necessary for the elimination of intracellular bacteria, might result in the suppression of specific T-cell functions. The extent to which activated macrophages can contribute to immunoregulation in CMI to intracellular bacteria via feedback mechanisms deserves further investigation.
